tradingkey.logo
tradingkey.logo
Search

BioNexus Gene Lab Corp

BGLC
Add to Watchlist
1.280USD
-0.040-3.03%
Close 07-31 16:00ETQuotes delayed by 15 min
3.09MMarket Cap
LossP/E TTM

BGLC Financials

See BioNexus Gene Lab Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

BioNexus Gene Lab Corp Earnings Date

Latest Release
May 15, 2026
EPS / Forecast
--/--
Revenue / Forecast
22.84K/--
Period
FY2025 Earnings
Revenue(YoY)
7.42M
-21.93%
EPS(YoY)
-1.61
-79.21%
Analyst Rating
--
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
35.18%-0.22
-162.47%-0.51
47.30%-0.39
-404.32%-0.34
-490.97%-0.35
-163.81%-0.19
48.92%-0.75
163.03%0.11
-22.29%-0.06
381.20%0.30
-2614.63%-1.47
---0.18
---0.05
---0.11
---0.05
----
----
----
----
----
Revenue
-98.93%22.84K
-80.83%483.76K
-3.29%2.54M
14.47%2.26M
-10.28%2.14M
11.03%2.52M
3.00%2.63M
-23.07%1.97M
0.20%2.38M
-19.95%2.27M
-0.83%2.55M
3.29%2.57M
-21.52%2.38M
-12.50%2.84M
-27.99%2.58M
-19.63%2.49M
-12.18%3.03M
-71.43%3.25M
15.69%3.58M
180.21%3.09M
Net Profit
12.79%-543.58K
-197.46%-1.04M
47.30%-708.99K
-409.47%-616.17K
-500.76%-623.33K
-213.31%-348.32K
48.42%-1.35M
176.80%199.10K
-50.23%-103.76K
295.85%307.42K
-3269.65%-2.61M
-86.97%-259.25K
-504.70%-69.07K
-275.89%-156.97K
-126.21%-77.40K
-590.63%-138.66K
-94.96%17.07K
-92.97%89.24K
25.96%295.32K
178.85%28.26K
Net Margin
-8058.85%-2379.72%
-1451.91%-214.18%
45.51%-27.87%
-370.36%-27.26%
-569.57%-29.17%
-202.05%-13.80%
49.92%-51.15%
199.84%10.08%
-49.94%-4.36%
344.66%13.52%
-3297.89%-102.13%
---10.10%
---2.91%
---5.53%
---3.01%
----
----
----
----
----
Gross Margin
-121.52%-3.46%
-106.72%-0.82%
19.60%14.85%
11.36%16.28%
4.88%16.07%
4.48%12.25%
-10.53%12.41%
10.48%14.62%
-1.24%15.33%
-1.84%11.73%
19.30%13.88%
--13.23%
--15.52%
--11.95%
--11.63%
----
----
----
----
----
Debt to assets ratio
--0.60%
----
----
----
----
----
----
----
----
----
----
----
----
--0.00%
--0.18%
----
----
----
----
----
Revenue
-98.93%22.84K
-80.83%483.76K
-3.29%2.54M
14.47%2.26M
-10.28%2.14M
11.03%2.52M
3.00%2.63M
-23.07%1.97M
0.20%2.38M
-19.95%2.27M
-0.83%2.55M
3.29%2.57M
-21.52%2.38M
-12.50%2.84M
-27.99%2.58M
-19.63%2.49M
-12.18%3.03M
-71.43%3.25M
15.69%3.58M
180.21%3.09M
Operating profit
-1.60%-563.29K
-164.81%-1.12M
42.07%-769.86K
-374.47%-622.43K
-363.90%-554.43K
-264.72%-422.85K
47.42%-1.33M
183.31%226.77K
-136.05%-119.52K
309.23%256.71K
-3775.59%-2.53M
-97.30%-272.20K
-245.95%-50.63K
-161.02%-122.69K
-117.50%-65.21K
-198.55%-137.96K
-89.86%34.69K
-86.10%201.06K
57.03%372.64K
512.05%139.99K
Net Profit
12.79%-543.58K
-197.46%-1.04M
47.30%-708.99K
-409.47%-616.17K
-500.76%-623.33K
-213.31%-348.32K
48.42%-1.35M
176.80%199.10K
-50.23%-103.76K
295.85%307.42K
-3269.65%-2.61M
-86.97%-259.25K
-504.70%-69.07K
-275.89%-156.97K
-126.21%-77.40K
-590.63%-138.66K
-94.96%17.07K
-92.97%89.24K
25.96%295.32K
178.85%28.26K
Current assets
-20.58%5.20M
-26.67%5.45M
-20.07%5.63M
-18.66%6.38M
-17.24%6.54M
-7.66%7.43M
-14.88%7.04M
50.05%7.84M
44.82%7.91M
33.63%8.05M
52.89%8.27M
-9.35%5.23M
-17.31%5.46M
-15.78%6.02M
-26.93%5.41M
-18.77%5.77M
-12.72%6.60M
-10.46%7.15M
927.78%7.40M
830.65%7.10M
Total current liabilities
-48.96%796.47K
-73.30%520.96K
-52.08%678.02K
25.62%1.76M
-9.10%1.56M
19.64%1.95M
-13.94%1.41M
-25.43%1.40M
9.80%1.72M
-18.62%1.63M
23.16%1.64M
24.89%1.88M
-21.23%1.56M
-13.94%2.00M
-49.91%1.33M
-41.67%1.50M
-34.62%1.98M
-30.97%2.33M
6882.74%2.66M
5445.06%2.58M
Total assets
-4.64%9.04M
-11.32%9.25M
-30.68%7.62M
-15.43%9.42M
-15.07%9.48M
-8.47%10.43M
-4.10%11.00M
41.03%11.14M
36.34%11.16M
30.43%11.40M
47.03%11.47M
-5.61%7.90M
-10.78%8.19M
-8.71%8.74M
-20.14%7.80M
-11.42%8.37M
-7.31%9.18M
-5.35%9.57M
863.76%9.77M
791.13%9.45M
Total liabilities
-44.57%946.88K
-69.78%637.86K
-49.91%804.97K
19.15%1.90M
-6.00%1.71M
21.19%2.11M
-9.61%1.61M
-17.63%1.59M
11.51%1.82M
-16.06%1.74M
29.33%1.78M
25.09%1.94M
-20.40%1.63M
-13.34%2.08M
-49.34%1.37M
-41.29%1.55M
-34.09%2.05M
-30.65%2.39M
3224.06%2.71M
2809.63%2.63M
Total equity
4.14%8.09M
3.51%8.61M
-27.40%6.82M
-21.20%7.52M
-16.83%7.77M
-13.82%8.32M
-3.09%9.39M
60.06%9.55M
42.51%9.34M
44.90%9.66M
50.81%9.69M
-12.58%5.96M
-8.01%6.56M
-7.17%6.67M
-8.91%6.42M
0.12%6.82M
4.94%7.13M
7.77%7.18M
656.94%7.05M
602.62%6.81M
Net operating income
81.88%-147.67K
1869.92%961.42K
13.34%-1.23M
-10.41%-729.28K
-2789.84%-815.14K
78.40%-54.32K
-63.05%-1.42M
-4256.81%-660.49K
74.26%-28.21K
-145.28%-251.47K
-370.76%-872.82K
91.92%-15.16K
-258.08%-109.61K
12.97%555.32K
-6.85%322.36K
79.03%-187.66K
-126.29%-30.61K
-31.14%491.57K
-54.35%346.05K
-474.51%-895.09K
Net investment
43.09%-13.99K
-101.25%-6.08K
546.27%990.45K
-152.20%-37.16K
-262.22%-24.58K
1948.88%485.68K
43.06%-221.94K
602.90%71.18K
210.21%15.15K
79.91%-26.27K
-12439.79%-389.81K
93.95%-14.15K
93.27%-13.75K
-54.11%-130.76K
103.56%3.16K
-234.48%-233.91K
31.15%-204.36K
-106.46%-84.85K
-8067.41%-88.76K
-478.78%-69.93K
Net financing
7042.91%59.71K
90.92%266.54K
117.36%34.19K
-100.59%-1.03K
-103.19%-860.00
957.75%139.61K
-103.43%-196.98K
--175.41K
--26.93K
--13.20K
--5.75M
-100.00%0.00
--0.00
100.00%0.00
100.00%0.00
1443.40%115.96K
100.00%0.00
-860.58%-4.96K
-378.18%-6.08K
-188.70%-8.63K

FAQs

What is the total revenue of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its total revenue reached 7.42M, with a year-on-year change of 9.51M.

What are the current assets of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its current assets were 5.45M, with a year-on-year change of -26.67.

What are the total assets of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its total assets of BioNexus Gene Lab Corp were 9.25M, with a year-on-year change of -11.32.

What are the total liabilities of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its total liabilities of BioNexus Gene Lab Corp were 637.86K, with a year-on-year change of -69.78.

What is the total equity of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its total equity of BioNexus Gene Lab Corp was 8.61M, with a year-on-year change of 3.51.

What is the net operating income of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its net operating income of BioNexus Gene Lab Corp was -3.10M, with a year-on-year change of -88.64.

What is the net investment of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its net investment of BioNexus Gene Lab Corp was 922.64K, with a year-on-year change of 163.56.

What is the net financing of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its net financing of BioNexus Gene Lab Corp was 298.84K, with a year-on-year change of 106.13.

What is the Earnings Per Share (EPS) of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -1.61, with a year-on-year change of -79.21.

What is the net income of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its net income was -2.98M, with a year-on-year change of -86.73.

What is the net margin of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its net profit margin was -40.20, with a year-on-year change of -139.19.

What is the gross margin of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its gross margin was 14.62, with a year-on-year change of 7.80.

What is the Return on Equity (ROE) of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its Return on Equity (ROE) was -35.24, with a year-on-year change of -98.23.

What is the Return on Assets (ROA) of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its Return on Assets (ROA) was -30.32, with a year-on-year change of -107.10.

What is the operating profit of BioNexus Gene Lab Corp?

According to BioNexus Gene Lab Corp's FY2025 earnings report, its operating profit was -3.10M, with a year-on-year change of -88.64.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.